are Kat and Kerry Logan, a sister-brother entrepreneurial team and the
co-founders of Advanced Vascular Therapies (AVT). We cared for our disabled
Mother (she suffered from multiple strokes (7+) and diabetes with very poor
circulation) for over 30 years. In her later years, our mother’s poor
circulation led to ‘non-healing wounds’ or ulcers on her legs/feet and
potential amputation. For our family, amputating our mother’s leg was not an
option. So, in that time we became skilled at wound care and prevention, and
from it, we developed innovative technology to aid in wound healing with the
larger goal to prevent amputation. We considered it a great privilege to have
our mother with us until she was 88 years old, and due to God’s grace, her
wonderful doctors, and our hard work and ingenuity she passed away with both
her legs and no ulcers (wounds) while she still lived in her own home, despite
We observed and met our Mother’s needs in innovative ways that led us to create our company to help others with similar needs.
skillsets are complementary with backgrounds in
Supervision (Kat) and Electrical Engineering (Kerry) from Purdue University. We
created AVT to help people with poor circulation retain their independence and
stay in their own homes with non-invasive therapeutic options. AVT is a seed
stage company and a Purdue University Foundry client. AVT is currently in the
prototyping stage of a novel pneumatic compression device (PCD) that we
designed to heal non-healing ulcers. Our device took 5 months to
completely heal a ‘non-healing ulcer’ on our mother, much better than the
standard of care device, which took 1.5 years on two separate occassions to
heal her wounds. Further, our device, used weekly, prevented further wound
formation, despite her extremely poor circulation.
AVT is extremely fortunate to have Dr. Steven J. Kavros serving as our Medical Director with over 35 years of experience in wound healing. Dr. Kavros has extensively researched pneumatic compression devices (PCD) related to limb salvage. He served as Director of Clinical Research at Gonda Vascular Wound Healing Center, Mayo Clinic, Rochester, MN. He is currently President of the American Professional Wound Care Association. His vast medical and business experience in the private sector is an invaluable resource to AVT.
AVT is proud to have Mr. Mike Hoffa lead our product development. He has over 24 years experience in product development and engineering support covering a broad range of medical devices and has a deep working knowledge of the legal, regulatory, quality, and manufacturing requirements. Mr. Hoffa worked at Hologic (VP Product Development), Suros Surgical Systems (Director of Engineering), and Cook Medical (Program Manager).
AVT developed a prototype of the novel PCD for non-healing ulcers that worked to save their mother’s limb
AVT’s Beta PCD is currently in use in an independent pilot to verify efficacy expected to complete in September 2017
AVT received a patent for their novel PCD – April 2017
AVT won the local InnovateHER competition at the Purdue Foundry in West Lafayette, IN – May 2017
AVT received a USDA Phase I SBIR to fund development of the final prototype for production – June 2017